It has been previously shown that elevated TH2 cytokines (IL-4, IL-10) and decreased TH1 cytokines (IFN-γ, IL-2 and IL-12) correlate with poorer prognoses in breast cancer patients than those with elevated TH1 and suppressed TH2 cytokines. This evidence concerns the gene IFNG and breast carcinoma.